Literature DB >> 18223504

Fructose intolerance in IBS and utility of fructose-restricted diet.

Young K Choi1, Nancy Kraft, Bridget Zimmerman, Michelle Jackson, Satish S C Rao.   

Abstract

INTRODUCTION: Whether dietary fructose intolerance causes symptoms of irritable bowel syndrome (IBS) is unclear. We examined the prevalence of fructose intolerance in IBS and long-term outcome of fructose-restricted diet.
METHODS: Two hundred and nine patients with suspected IBS were retrospectively evaluated for organic illnesses. Patients with IBS (Rome II) and positive fructose breath test received instructions regarding fructose-restricted diet. One year later, their symptoms, compliance with, and effects of dietary modification on lifestyle were assessed using a structured interview.
RESULTS: Eighty patients (m/f=26/54) fulfilled Rome II criteria. Of 80 patients, 31 (38%) had positive breath test. Of 31 patients, 26 (84%) participated in follow-up (mean=13 mo) evaluation. Of 26 patients, 14 (53%) were compliant with diet; mean compliance=71%. In this group, pain, belching, bloating, fullness, indigestion, and diarrhea improved (P<0.02). Of 26 patients, 12 (46%) were noncompliant, and their symptoms were unchanged, except belching. The mean impact on lifestyle, compliant versus noncompliant groups was 2.93 versus 2.57 (P>0.05).
CONCLUSIONS: About one-third of patients with suspected IBS had fructose intolerance. When compliant, symptoms improved on fructose-restricted diet despite moderate impact on lifestyle; noncompliance was associated with persistent symptoms. Fructose intolerance is another jigsaw piece of the IBS puzzle that may respond to dietary modification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223504     DOI: 10.1097/MCG.0b013e31802cbc2f

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  36 in total

1.  The treatment of irritable bowel syndrome.

Authors:  Brian E Lacy; Kirsten Weiser; Ryan De Lee
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.

Authors:  Mercedes Amieva-Balmori; Enrique Coss-Adame; Nikilesh S Rao; Brisa M Dávalos-Pantoja; Satish S C Rao
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

3.  Fructose malabsorption is not uncommon among patients with irritable bowel syndrome in India: a case-control study.

Authors:  Atul Sharma; Deepakshi Srivastava; Abhai Verma; Asha Misra; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2014-07-29

Review 4.  Dietary fructose intolerance, fructan intolerance and FODMAPs.

Authors:  Amy Fedewa; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2014-01

5.  Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?

Authors:  Brian E Lacy; Scott L Gabbard; Michael D Crowell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

6.  Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort.

Authors:  A Mack; J S Bobardt; A Haß; K B Nichols; R M Schmid; C K Stein-Thoeringer
Journal:  Gut Microbes       Date:  2019-12-06

7.  Caecal pH is a biomarker of excessive colonic fermentation.

Authors:  Adam D Farmer; Sahar D Mohammed; George E Dukes; S Mark Scott; Anthony R Hobson
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 8.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 9.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

Review 10.  Fructose-sorbitol malabsorption.

Authors:  Fernando Fernández-Bañares; Maria Esteve; Josep M Viver
Journal:  Curr Gastroenterol Rep       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.